Genomic Valley Biotech reports standalone net profit of Rs 0.15 crore in the March 2022 quarter

Reported sales nil

Net profit of Genomic Valley Biotech reported to Rs 0.15 crore in the quarter ended March 2022 as against net loss of Rs 0.38 crore during the previous quarter ended March 2021. There were no Sales reported in the quarter ended March 2022 as against Rs 0.02 crore during the previous quarter ended March 2021.

For the full year,net loss reported to Rs 0.01 crore in the year ended March 2022 as against net loss of Rs 0.56 crore during the previous year ended March 2021. Sales declined 66.67% to Rs 0.07 crore in the year ended March 2022 as against Rs 0.21 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales00.02 -100 0.070.21 -67 OPM %0-500.00 --542.86-61.90 - PBDT-0.31-0.28 -11 -0.34-0.31 -10 PBT-0.26-0.32 19 -0.42-0.50 16 NP0.15-0.38 LP -0.01-0.56 98

Powered by Capital Market - Live News